Tim Bertram

Mr. Bertram is Chief Executive Officer of inRegen, a multi-national privately owned clinical-stage cellular therapeutics company focusing on treatment of chronic renal disease. He also serves as CEO of Twin City Bio, a USA-based CDMO focusing on the manufacturing and Development of cell-based therapeutics. As a Director for multiple biotechnology companies, he brings over 35 years of medicine development leadership to public and private companies. Previously, Mr. Bertram was a senior executive at Pfizer, SmithKline Beecham Pharmaceuticals, and Procter & Gamble Corporate Research were his career focused on taking molecular entities from research through clinical development and registration. These development efforts lead to the commercialization of eight medical products that are changing lives around the world. Tim started his professional career on faculty at the University of Illinois and as a visiting scientist at the National Institutes of Health.